Malik Fady Ibraham

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
85
Insider Sells Sum
$26.51M

Insider Activity of Malik Fady Ibraham

According to the SEC Form 4 filings, Malik Fady Ibraham, being in a position of

  1. EVP Research & Development at Cytokinetics, Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 186570 shares for $11.34M,
    over all time since 2014-12-30, has bought 0 shares, and sold 590830 shares for $26.51M.

The largest sale of all time was on 2024-02-06 and amounted to 32605 shares of Cytokinetics, Incorporated for $2.59M.

Biography of Malik Fady Ibraham

No biography is available at this moment.

2025-02-04SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
2,000
0.0017%
$48.06$96,120-5.57%
2025-01-21SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
2,000
0.0017%
$45.92$91,840+7.1%
2025-01-07SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
2,000
0.0017%
$49.32$98,640-0.67%
2024-12-10SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
7,300
0.0062%
$50.64$369,639-3.76%
2024-11-26SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
7,300
0.006%
$50.16$366,181-5.83%
2024-11-12SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
6,342
0.0056%
$58.48$370,880-12.65%
2024-10-30SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
7,300
0.0063%
$51.91$378,930-4.11%
2024-10-15SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
7,300
0.0064%
$54.19$395,554-9.82%
2024-10-01SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
7,300
0.0061%
$52.10$380,297-4.11%
2024-09-17SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
7,300
0.0063%
$56.77$414,401-9.78%
2024-09-03SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
7,384
0.0066%
$57.01$420,973-6.21%
2024-08-20SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
7,300
0.0061%
$56.25$410,638-9.12%
2024-08-06SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
7,300
0.0062%
$53.71$392,090-2.99%
2024-07-23SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
5,300
0.0046%
$57.02$302,206+0.63%
2024-07-09SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
7,300
0.0069%
$55.90$408,1030%
2024-06-25SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
7,300
0.0065%
$53.72$392,143-0.49%
2024-06-11SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
7,788
0.0068%
$53.04$413,106-0.94%
2024-05-07SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
15,547
0.0149%
$65.11$1.01M-18.8%
2024-04-09SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
32,605
0.0313%
$74.31$2.42M-28.02%
2024-03-05SaleCytokinetics, Incorporated
CYTK
EVP Research & Development
32,604
0.032%
$67.56$2.2M-17.39%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.